drugset / Trial / NCT06509893

Ticagrelore Alone Post PCI

NCT06509893

Phase 4 Recruiting 5400 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

After PCI for CCS patients, single center double blind randomization will be done and patients will receive aspirin 80 mg and clopidogrel 75 mg versus 90 mg two times daily of ticagrelor, for 6 months and MACE will be followed in registry of professor Kojuri cardiology clinic

Timeline

Start
2024-08-01
Primary completion
2025-12-01
Completion
2026-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 80 mg
Comparator Clopidogrel Small molecule 75 mg
Subject Ticagrelor Small molecule 90 mg Oral